Fate Therapeutics Announces Proposed Public Offering of Common Stock

Go back to Fate Therapeutics Announces Proposed Public Offering of Common Stock
FATE THERAPEUTICS (NASDAQ: FATE) Delayed: 2.49 +0.04 (1.63%)
Previous Close $2.45    52 Week High $4.76 
Open $2.46    52 Week Low $1.46 
Day High $2.51    P/E N/A 
Day Low $2.45    EPS $-1.91 
Volume 396,457